Clinical Trial Update: A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030) [Phase 1]

View source ↗

Summary

Phase 1 study of Enlicitide Decanoate in individuals with liver impairment and hepatic insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Enlicitide Decanoate (Enlicitide Decanoate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatic Insufficiency, Hepatic Impairment | Phase 1 | Status: COMPLETED